Barinthus Biotherapeutics (BRNS) Share-based Compensation Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -69.95% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.18% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 28.59 Mn | -38.52 Mn | - | 18.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.80% |
| Dec 31, 2025 | -7.81% |
| Sep 30, 2025 | -136.28% |
| Jun 30, 2025 | -123.51% |
| Mar 31, 2025 | -71.02% |
| Dec 31, 2024 | -3.94% |
| Sep 30, 2024 | 1,907.02% |
| Jun 30, 2024 | -39.95% |
| Mar 31, 2024 | -27.32% |
| Dec 31, 2023 | -61.49% |
| Sep 30, 2023 | -94.84% |
| Jun 30, 2023 | -27.58% |
| Mar 31, 2023 | -44.23% |
| Dec 31, 2022 | -42.99% |
| Sep 30, 2022 | -67.28% |
| Jun 30, 2022 | -68.54% |
| Mar 31, 2022 | 399.87% |
| Dec 31, 2021 | 62.73% |
| Sep 30, 2021 | 2,090.91% |
| Jun 30, 2021 | 2,005.06% |